Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Non Operating Income of -$10.0 million in Q4 2025, up 5.05% quarter-over-quarter from -$10.5 million in Q3 2025, and down 2734.28% on a YoY basis from $379800.5 in Q4 2024.
Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Non Operating Income history runs 16 years deep, the most recent figure standing at -$10.0 million for Q4 2025.
- In Q4 2025, Non Operating Income fell 2734.28% year-over-year to -$10.0 million; the TTM figure through Dec 2025 stood at -$24.0 million (up 74.27% YoY), while the FY2025 annual figure was -$5.0 million, up 92.54% from the prior year.
- Non Operating Income was -$10.0 million for Q4 2025 at Prestige Consumer Healthcare, up from -$10.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $49.9 million in Q1 2022 to a low of -$68.7 million in Q1 2023.
- Historically, Non Operating Income has averaged -$12.7 million across 5 years, with a median of -$11.6 million in 2024.
- Biggest YoY gain for Non Operating Income was 263.42% in 2022; the steepest drop was 15449.52% in 2022.
- A 5-year view of Non Operating Income shows it stood at -$17.1 million in 2021, then decreased by 11.5% to -$19.1 million in 2022, then surged by 96.42% to -$682000.0 in 2023, then soared by 48.24% to -$353000.0 in 2024, then slumped by 2734.28% to -$10.0 million in 2025.
- The last three Non Operating Income figures came in at -$10.0 million (Q4 2025), -$10.5 million (Q3 2025), and $224000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Prestige Consumer Healthcare | 2.33 Bn | 2.26 Bn | 157.37 Mn | -10.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.01 Mn |
| Sep 30, 2025 | -10.54 Mn |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -353,000.00 |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | -66.73 Mn |
| Dec 31, 2023 | -682,000.00 |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | -68.71 Mn |
| Dec 31, 2022 | -19.07 Mn |
| Sep 30, 2022 | -17.79 Mn |
| Jun 30, 2022 | -16.12 Mn |
| Mar 31, 2022 | 49.95 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Sep 30, 2021 | -493,000.00 |
| Jun 30, 2021 | 105,000.00 |
| Mar 31, 2021 | -30.56 Mn |